Kynam Capital Management as of Dec. 31, 2021
Portfolio Holdings for Kynam Capital Management
Kynam Capital Management holds 31 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Global Blood Therapeutics In | 16.8 | $32M | 1.1M | 29.27 | |
| Xenon Pharmaceuticals (XENE) | 11.0 | $21M | 670k | 31.24 | |
| Syndax Pharmaceuticals (SNDX) | 11.0 | $21M | 956k | 21.89 | |
| Gossamer Bio (GOSS) | 6.1 | $12M | 1.0M | 11.31 | |
| Biogen Idec (BIIB) | 5.1 | $9.6M | 40k | 239.93 | |
| Celldex Therapeutics Com New (CLDX) | 4.6 | $8.8M | 227k | 38.64 | |
| Amarin Corp Spons Adr New (AMRN) | 3.9 | $7.5M | 2.2M | 3.37 | |
| Vera Therapeutics Cl A (VERA) | 3.6 | $6.8M | 253k | 26.72 | |
| Liquidia Corporation Com New (LQDA) | 3.5 | $6.7M | 1.4M | 4.87 | |
| Amicus Therapeutics (FOLD) | 3.5 | $6.6M | 574k | 11.55 | |
| Miragen Therapeutics (VRDN) | 3.0 | $5.7M | 288k | 19.77 | |
| Travere Therapeutics (TVTX) | 3.0 | $5.7M | 182k | 31.04 | |
| Fate Therapeutics (FATE) | 2.9 | $5.6M | 96k | 58.51 | |
| Vaxcyte (PCVX) | 2.6 | $5.0M | 212k | 23.79 | |
| Wave Life Sciences SHS (WVE) | 2.5 | $4.7M | 1.5M | 3.14 | |
| Merus N V (MRUS) | 2.0 | $3.9M | 122k | 31.80 | |
| Burning Rock Biotech Sponsored Ads (BNR) | 1.9 | $3.6M | 383k | 9.53 | |
| Zogenix Com New | 1.8 | $3.3M | 206k | 16.25 | |
| Olema Pharmaceuticals (OLMA) | 1.4 | $2.7M | 294k | 9.36 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.4 | $2.7M | 239k | 11.26 | |
| Seres Therapeutics (MCRB) | 1.3 | $2.5M | 305k | 8.33 | |
| Cabaletta Bio (CABA) | 1.3 | $2.4M | 645k | 3.79 | |
| Krystal Biotech (KRYS) | 1.3 | $2.4M | 35k | 69.94 | |
| Puma Biotechnology (PBYI) | 1.1 | $2.1M | 684k | 3.04 | |
| Affimed Therapeutics B V | 1.1 | $2.0M | 364k | 5.52 | |
| Radius Health Com New | 0.7 | $1.3M | 194k | 6.92 | |
| Cogent Biosciences (COGT) | 0.7 | $1.3M | 150k | 8.58 | |
| Akouos | 0.4 | $842k | 99k | 8.50 | |
| Neoleukin Therapeutics | 0.4 | $709k | 147k | 4.82 | |
| Catalyst Biosciences Com New | 0.1 | $101k | 111k | 0.91 | |
| Allakos Call Option (ALLK) | 0.0 | $2.0k | 75k | 0.03 |
